ArticleFrontiers in pharmacology2025

Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes.

Feng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.